FDA Approves Abbott's Novel Dissolvable Stent Therapy for Peripheral Artery Disease
HCPLive
APRIL 29, 2024
Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.
HCPLive
APRIL 29, 2024
Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.
Med Page Today
APRIL 29, 2024
(MedPage Today) -- The FDA approved the Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the knee, Abbott announced on Monday. This system represents the first drug-eluting resorbable scaffold with.
DAIC
JUNE 4, 2024
The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck.
The American Journal of Cardiology
APRIL 9, 2025
Publication date: Available online 8 April 2025 Source: The American Journal of Cardiology Author(s): Subhash Banerjee, David Fernandez Vazquez, Yu-Lun Liu, Sameh Sayfo, Minseob Jeong, Zachary P. Rosol, Anand Gupta, Blake M. Bruneman, Sarah G. Weideman, Kennedy S. Adelman, Shirling Tsai, Shuaib Abdullah, Hung B. Chu, Bertram L. Smith, Bradley R.
DAIC
APRIL 11, 2024
The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. The study was funded by Medtronic, Inc. and Korea United Pharm.
DAIC
MARCH 14, 2025
Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation (..)
DAIC
MAY 30, 2024
The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic-35 cobalt chromium balloon-expandable stent system. At baseline, 12.5% Brodmann M.
Let's personalize your content